# Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

> **NCT00610935** · PHASE3 · TERMINATED · sponsor: **BioCryst Pharmaceuticals** · enrollment: 82 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Peramivir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00610935
- **Lead sponsor:** BioCryst Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 82 (ACTUAL)
- **Why stopped:** This study was terminated for administrative reasons.
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00610935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00610935, "Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00610935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*